GlassScriptPhysician profile
Megan Mccartney
NPI 1871163527
$1,477.30
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $472 · 2023: $460 · 2024: $218 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $245.65 | 2022-2024 | Monoferric |
| Janssen Pharmaceuticals, INC | $242.61 | 2021-2023 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.35 | 2023-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $150.85 | 2023-2024 | Inpefa |
| Octapharma USA, INC. | $121.44 | 2023 | Wilate - Von Willebrand Factor/Coagulation Factor Viii Complex (Human) |
| Esperion Therapeutics, INC. | $112.33 | 2022-2025 | Nexletol |
| Janssen Biotech, INC. | $107.73 | 2021 | |
| Incyte Corporation | $107.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $102.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.65 | 2022-2025 | Lifevest |
| Cvrx, INC. | $23.95 | 2024 | Barostim Neo System |
| Daiichi Sankyo INC. | $22.12 | 2025 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mccartney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.